Study to Assess the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Effects of a Single Dose of REGN5713-5714-5715 in Healthy Adult Participants
Clinical trial NCT03969849 · COMPLETED
Trial details
- NCT number
- NCT03969849
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-03
- Primary completion
- 2020-03-27
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.